Peer-reviewedCC BY-NC 4.0Haematologica28 May 2026

On closing the gap: anti-PD-1-based salvage in relapsed/ refractory classical Hodgkin lymphoma. Comment on: “Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma”

Hishan Tharmaseelan¹
Bastian von Tresckow^1,2

¹University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), Cologne
²Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Duisburg-Essen, University Hospital Essen, Essen, Germany

The gap narrows but shifts. Response to Comment on: “Mind the gap: anti–PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma”
Daniel Noerenberg
Haematologica4 Jun 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
Follicular Lymphoma Presenting as Refractory Panniculitis-like Lesions: A Case Report of Successful Salvage with Autologous Stem Cell Transplantation
Kristina Alaiyoud, Nikolett Farmasi, Zsófia Miltényi +3
Journal of Clinical Medicine27 Oct 2026Peer-reviewedCC BY 4.0General medicineCrossref
Addition of thiotepa to total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute leukemia and lymphoma: a propensity score-matched retrospective study.
Minglu Li, Shuqin Zhang, Xiaoyong Man +4
Annals of hematology1 Jul 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
PD-1-based combination therapy versus monotherapy in relapsed or refractory classical Hodgkin lymphoma: a single-center retrospective cohort study
Weiming Zhang, Nasha Yu, Qiang Ding +3
Frontiers in Oncology4 Nov 2026Peer-reviewedCC BY 4.0OncologyFrontiersCrossref
Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.
Melissa K Shields, Richard J Woodman, Stewart R Lake +2
BMJ open8 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref

Cite

BibTeX

@article{tharmaseelan2026closing,
  title = {{On closing the gap: anti-PD-1-based salvage in relapsed/ refractory classical Hodgkin lymphoma. Comment on: “Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma”}},
  author = {Hishan Tharmaseelan and Bastian von Tresckow},
  journal = {Haematologica},
  year = {2026},
  month = may,
  doi = {10.3324/haematol.2026.301234},
  url = {https://doi.org/10.3324/haematol.2026.301234},
  note = {CC BY-NC 4.0},
}

RIS

TY  - JOUR
TI  - On closing the gap: anti-PD-1-based salvage in relapsed/ refractory classical Hodgkin lymphoma. Comment on: “Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma”
AU  - Hishan Tharmaseelan
AU  - Bastian von Tresckow
PY  - 2026
DA  - 2026/05/28
JO  - Haematologica
DO  - 10.3324/haematol.2026.301234
UR  - https://doi.org/10.3324/haematol.2026.301234
SN  - 0390-6078
SN  - 1592-8721
ER  -

Related

Cite